Ligand Pharmaceuticals
LGND
#4198
Rank
NZ$3.42 B
Marketcap
$177.75
Share price
-5.17%
Change (1 day)
44.93%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.53

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.71. In 2022 the company made an earnings per share (EPS) of -$3.41 a decrease over its 2021 EPS that were of $5.96.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.53-174.26%
2022-$3.41-157.23%
2021$5.96-2571.43%
2020-$0.24-100.46%
2019$52.77353.48%
2018$11.641025%
2017$1.03-700%
2016-$0.17-100.87%
2015$19.931859.32%
2014$1.025.36%
2013$0.978.0704505322479E+18%
2012$0.0000000000-100%
2011$0.84-194.23%
2010-$0.90548.38%
2009-$0.14-98.7%
2008-$10.65-136.52%
2007$29.17-787.8%
2006-$4.24-14.58%
2005-$4.96-21.31%
2004-$6.31-55.15%
2003-$14.0781.33%
2002-$7.762.74%
2001-$7.55-45.93%
2000-$13.96-14.56%
1999-$16.34-45.52%
1998-$30.00-3.97%
1997-$31.24132.31%
1996-$13.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$24.39 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.62-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.03 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.14 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.21 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.36 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.84 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.83 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.28 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA